» Articles » PMID: 32640171

You Say You Want a Resolution (of Fibrosis)

Overview
Date 2020 Jul 9
PMID 32640171
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

In pathological fibrosis, aberrant tissue remodeling with excess extracellular matrix leads to organ dysfunction and eventual morbidity. Diseases of fibrosis create significant global health and economic burdens and are often deadly. Although fibrosis has traditionally been thought of as an irreversible process, a growing body of evidence demonstrates that organ fibrosis can reverse in certain circumstances, especially if an underlying cause of injury can be removed. This body of evidence has uncovered more and more contributors to persistent and nonresolving tissue fibrosis. Here, we review the present knowledge on resolution of organ fibrosis and restoration of near-normal tissue architecture. We emphasize three critical areas of tissue homeostasis that are necessary for fibrosis resolution, namely, the elimination of matrix-producing cells, the clearance of excess matrix, and the regeneration of normal tissue constituents. In so doing, we also highlight how profibrotic pathways interact with one another and where there may be therapeutic opportunities to intervene and remediate pathological persistent fibrosis.

Citing Articles

Fighting Bleb Fibrosis After Glaucoma Surgery: Updated Focus on Key Players and Novel Targets for Therapy.

Sacchi M, Tomaselli D, Ruggeri M, Aiello F, Sabella P, Dore S Int J Mol Sci. 2025; 26(5).

PMID: 40076946 PMC: 11900438. DOI: 10.3390/ijms26052327.


Distinct cAMP regulation in scleroderma lung and skin myofibroblasts governs their dedifferentiation via p38α inhibition.

Baas J, Varga J, Feghali-Bostwick C, Peters-Golden M, Fortier S bioRxiv. 2025; .

PMID: 40060695 PMC: 11888450. DOI: 10.1101/2025.02.26.640163.


Cytokine priming enhances the antifibrotic effects of human adipose derived mesenchymal stromal cells conditioned medium.

Brizio M, Mancini M, Lora M, Joy S, Zhu S, Brilland B Stem Cell Res Ther. 2024; 15(1):329.

PMID: 39334258 PMC: 11438190. DOI: 10.1186/s13287-024-03916-9.


BCL-2 Modulates IRE1α Activation to Attenuate Endoplasmic Reticulum Stress and Pulmonary Fibrosis.

Jourdan Le Saux C, Ho T, Brumwell A, Kathiriya J, Wei Y, Hughes J Am J Respir Cell Mol Biol. 2023; 70(4):247-258.

PMID: 38117250 PMC: 11478128. DOI: 10.1165/rcmb.2023-0109OC.


Omentin-1 induces mechanically activated fibroblasts lipogenic differentiation through pkm2/yap/pparγ pathway to promote lung fibrosis resolution.

Zhang Y, Fu J, Li C, Chang Y, Li X, Cheng H Cell Mol Life Sci. 2023; 80(10):308.

PMID: 37768341 PMC: 11072733. DOI: 10.1007/s00018-023-04961-y.


References
1.
Borthwick L, Barron L, Hart K, Vannella K, Thompson R, Oland S . Macrophages are critical to the maintenance of IL-13-dependent lung inflammation and fibrosis. Mucosal Immunol. 2015; 9(1):38-55. PMC: 4626445. DOI: 10.1038/mi.2015.34. View

2.
Adler M, Mayo A, Zhou X, Franklin R, Meizlish M, Medzhitov R . Principles of Cell Circuits for Tissue Repair and Fibrosis. iScience. 2020; 23(2):100841. PMC: 7005469. DOI: 10.1016/j.isci.2020.100841. View

3.
Parker M, Rossi D, Peterson M, Smith K, Sikstrom K, White E . Fibrotic extracellular matrix activates a profibrotic positive feedback loop. J Clin Invest. 2014; 124(4):1622-35. PMC: 3971953. DOI: 10.1172/JCI71386. View

4.
Ikenaga N, Peng Z, Vaid K, Liu S, Yoshida S, Sverdlov D . Selective targeting of lysyl oxidase-like 2 (LOXL2) suppresses hepatic fibrosis progression and accelerates its reversal. Gut. 2017; 66(9):1697-1708. PMC: 5561383. DOI: 10.1136/gutjnl-2016-312473. View

5.
Horowitz J, Ajayi I, Kulasekaran P, Rogers D, White J, Townsend S . Survivin expression induced by endothelin-1 promotes myofibroblast resistance to apoptosis. Int J Biochem Cell Biol. 2011; 44(1):158-69. PMC: 3241828. DOI: 10.1016/j.biocel.2011.10.011. View